Groundbreaking Research Project Investigates Stem Cell Mutations in Rare Blood Disorder

SKAN Research Trust, Wellcome Sanger Institute, and University of Newcastle collaborate on a groundbreaking research project to investigate early stem cell mutations in Langerhans Cell Histiocytosis (LCH). Led by Dr. Jyoti Nangalia, the study aims to analyze genetic mutations, understand disease progression, and identify early intervention strategies for effective management. This research endeavors to shed light on the complexities of LCH and potentially pave the way for personalized treatment approaches.